the aid library

LIST OPTIONS

Filter

7113

Primary Prevention of Diabetes

MV Hospitals for Diabetes & Diabetes Research Centre (WHO), India (2016) C_WHO

This manual aims to provide an overview of this subject to health care professionals, paramedics and other voluntary services involved in health care promotion

Download (1223)

View PDF (1490)

Youth-Friendly Services - A Manual for Service Providers

EngenderHealth (2002)

All young people, including those with special needs and from the most vulnerable groups, have the right to quality health care services. Unfortunately, this right is not a reality, particularly in the case of sexual and reproductive health services. Many youth in need of sexual and reproductive hea... more

Download (419)

View PDF (393)

Positive health, dignity and prevention for women and their babies. Flipchart

Inter-Agency Task Team (IATT) (2018) C1

A treatment literacy guide for pregnant women and mothers living with HIV
Positive Health, Dignity and Prevention for Women and their Babies is intended for use by networks of women living with HIV, women’s groups, peer educators and others wishing to help guide women living with HIV t... more

Download (180)

View PDF (389)

Secondhand Smoke Exposure and the Impact of Smokefree Policies

Centers for Disease Control and Prevention (2021) CC

The Public Health Burden of Secondhand Exposure to Commercial Tobacco Smoke Secondhand smoke, the combination of smoke from burning commercial tobacco* products and the smoke breathed out by a person who is smoking, is deadly.

Download (309)

View PDF (610)

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

Download (247)

View PDF (252)

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 3

World Health Organization (WHO) World Health Organization (WHO) (2017) C_WHO

Module 3 Counsellors July 2017 Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea... more

Download (382)

View PDF (484)

Bearing the brunt: The impact of COVID-19 on older people in low- and middle-income countries – insights from 2020

HelpAge (2021) C1

The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with... more

Download (400)

View PDF (250)

Barbados National Action Plan on Combatting Antimicrobial Resistance 2017-2022

MINISTRY OF HEALTH, BARBADOS (2017) C_WHO

Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr... more

External Link

Trends in infant mortality in Venezuela between 1985 and 2016: a systematic analysis of demographic data

Jenny García, Gerardo Correa, Brenda Rousset (2019) CC

Lancet Glob Health 2019 Published Online January 24, 2019 http://dx.doi.org/10.1016/S2214-109X(18)30479-0 The health-care system collapse underway in Venezuela is a cause of utmost concern for its people and, increasingly, for the wider region. Declines in provision of basic services, such as ... more

Download (232)

View PDF (143)

Comprehensive Tobacco Control Programs

Centers for Disease Control and Prevention (2021) CC

The Public Health Burden of Commercial Tobacco Use The burden of disease and death from commercial tobacco* use in the United States is overwhelmingly caused by cigarettes and other combustible tobacco products.

Download (365)

View PDF (591)

Alzheimer's disease facts and figures

J. Gaugler, Ph.D.; B. James, Ph.D.; T. Johnson, Ph.D., et al. Alzheimer's Association (2018) C2

Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis 2018 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’s disease, the most common cause of dementia. Background and context for interpretating the data are con... more

Download (320)

View PDF (318)

Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended

NdOH South Africa National Department of Health South Africa (2018) C1

These guidelines form part of efforts to institutionalize the prevention and containment of antimicrobial resistance (AMR) in healthcare facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two interr... more

Download (422)

View PDF (702)

Health and Human Rights in the new world (dis)order

British Medical Association BMA (2022) CC

Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK. 'Health and human rights in the new world (dis)order' outlines a shifting rights landscape in which new ... more

Download (275)

View PDF (482)

Venezuela’s Humanitarian Emergency

Human Rights Watch (2019) C1

Large-Scale UN Response Needed to Address Health and Food Crises This report is based on interviews with more than 150 health care professionals, Venezuelans seeking or in need of medical care who recently arrived in Colombia and Brazil, representatives from international and nongovernmental humani... more

Download (305)

View PDF (302)

COVID-19 infection prevention and control for primary care, including general practitioner practices, dental clinics and pharmacy settings. First Update

European Centre for Disease Prevention and Control ECDC (2020) C1

Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels and mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific heal... more

Download (429)

View PDF (735)

CONTINUING PROFESSIONAL DEVELOPMENT (CPD) POLICY FOR HEALTH PROFESSIONAL COUNCILS IN RWANDA

Rwanda Medical and Dental Council (RMDC), National Council for Nurses and Midwives (NCNM), National Pharmacy Council (NPC) and Rwanda Allied Health Professionals Council (RAHPC) (2013) C2

This CPD Policy relates to all health professionals in the four Health Professional Councils in Rwanda namely; RMDC, NCNM, RAHPC, and RPC. The policy requires all health professionals to participate in the CPD Programs. The purpose of this CPD Policy is to support the professionals in the respective... more

Download (537)

View PDF (529)

Robson Classification: Implementation Manual

World Health Organization (2017) C_WHO

In 2015, WHO proposed the use of the Robson classification (also known as the 10-group classification) as a global standard for assessing, monitoring and comparing caesarean section rates both within healthcare facilities and between them. The system classifies all women into one of 10 categories t... more

Download (454)

View PDF (687)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Factsheet for experts - Antimicrobial resistance

European Centers for Disease Control and Prevention ECDC (2019) CC

Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th... more

Download (338)

View PDF (453)

Practical Manual for Implementation of the National Infection Prevention and Control Strategic Framework - 2020

National Department of Health South Africa (2020) CC

The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ... more

Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals recommended

Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended